THE CANNABIS INNOVATION CENTER - THE "CIC"
The Cannabis Innovation center is an Israeli biotech innovation group with a specialty in the fields of Cannabis with main strengths in the pharmaceutical space through its vast experience and activities.
Stero Biotechs – a pharmaceutical startup company developing a CBD-based steroid sparing treatment with a strong IP, ongoing phase 2a clinical trials with more indications in the pipeline for
CannaLean Biotechs – a pharmaceutical startup company developing a novel formulation to lower the lipid blood levels in patients with dyslipidemia with 3 successful pre-clinical trials with 2 clinical trials in the pipeline
CannaMore Biotechs – a pre-clinical and clinical stage research platform company committed to the development of novel and improved cannabis-based treatment options with a groundbreaking partnership with the largest HMO in Israel with multiple clinical trials in the pipeline
BioSeed – a biotech & Cannabis startup incubator that provides the perfect eco-system for startup companies in the vast field of Biotech and Cannabis in particular, with dedication to support early stage startups, providing them all the necessary tools guidance ,R&D support and more. BioSeed specializes in biotech with an emphasis on Cannabis in the fields of pharma, medical device, diagnostics, OTC and cosmetics.
CannaDu – an exclusive Biotech Venture Capital fund, focused on Cannabis investments in fields of Pharmaceuticals, wellness, medical applications & devices.
the CIC's current & future clinical trials pipeline
| Indication | phase |
|---|---|
| GvHD prevention | 2b |
| Crohn's Disease | 2a |
| Urticaria | 2a |
| Covid-19 | 1/2 |
| Cholesterol | 2a |
| Paucities | 2a |
| Peripheral Neuropathy | 2a |
| Bronchiolitis Obliterans treatment | 2a |
| Triglycerides | 2a |
| GvHD treatment | 2b |
| COPD & Asthma /Autoimmune | 2a |
| Ulcerative colitis | 2a |
| Bronchiolitis Obliterans prevention | 2a |
| GvHD prevention | 3 |